Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

September 29, 2022

Bioscience company to relocate headquarters, lab to Woodbridge

Contributed 4 Research Drive, Woodbridge.
By Andrew Larson

A clinical-stage nonprofit biotechnology company, Cure Rare Disease, has acquired its first laboratory space in Woodbridge.

The organization will relocate its Boston headquarters to the 30,000-square-foot facility at 4 Research Drive and expand its research and development operations. The company plans to lease 15,000 square feet to other life science and healthcare firms.

Cure Rare Disease develops therapeutics for rare and ultra-rare neuromuscular diseases, such as two rare types of muscular dystrophy, known as Duchenne and Becker.

“We are excited to join the Woodbridge and greater New Haven communities to deepen our R&D efforts for rare disease patients while also offering biotechnology companies the opportunity to access Class A life sciences space in the New Haven area,” said founder and CEO Rich Horgan.

Horgan’s brother, Terry, was diagnosed with Duchenne muscular dystrophy in 1999. There is no cure, but Horgan hopes to change that.

“A family impacted by rare disease only has two options: fight or stand idly by,” Horgan says on the company’s website. “Standing by wasn’t an option.”

The space will be renovated through the end of 2022 and into 2023, with New Haven firm Svigal+Partners overseeing the architectural work.

The renovations were partially funded by a grant from the Health Resources and Services Administration.

Sign up for Enews

Most Recent

Most Recent

0 Comments

Order a PDF